Usage prevalence of angioedema patient-reported outcome measures: Results from the UCARE and ACARE PROMUSE study

Cherrez-Ojeda, IvanGiménez Arnau, Anna MariaPesqué, DavidMaurer, Marcus2025-06-052025-06-052024Cherrez-Ojeda I, Bousquet J, Giménez-Arnau A, Godse K, Krasowska D, Bartosińska J, et al. Usage prevalence of angioedema patient-reported outcome measures: Results from the UCARE and ACARE PROMUSE study. J Allergy Clin Immunol Pract. 2024 Aug;12(8):2211-5.e1. DOI: 10.1016/j.jaip.2024.04.0562213-2198http://hdl.handle.net/10230/70617application/pdfeng© 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. This is an open access article under the CC BY NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Usage prevalence of angioedema patient-reported outcome measures: Results from the UCARE and ACARE PROMUSE studyinfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.jaip.2024.04.056info:eu-repo/semantics/openAccess